A carregar...

Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection

Respiratory Syncytial Virus (RSV) infects almost all children under the age of one and is the leading cause of hospitalization among infants. Despite several decades of research with dozens of candidate vaccines being vigorously evaluated in pre-clinical and clinical studies, there is no licensed va...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Muralidharan, Abenaya, Russell, Marsha, Larocque, Louise, Gravel, Caroline, Li, Changgui, Chen, Wangxue, Cyr, Terry, Lavoie, Jessie R., Farnsworth, Aaron, Rosu-Myles, Michael, Wang, Lisheng, Li, Xuguang
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6226510/
https://ncbi.nlm.nih.gov/pubmed/30413743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-34999-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!